Maluba, Salasina M.
HRN: 28-46-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2026
CEFTRIAXONE 1G (VIAL)
01/21/2026
01/27/2026
IV
2g
OD
T/C Sepsis Sec To UTI
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines